lenalidomide,pomalidomide,dexamethasone,bortezomib
bms,takeda
['determination', 'mmsm', 'ifm,2009,2']
len/dex led to higher than expected discontinuations and progressions prior to asct which accounted for the high drop out. in total, i will put more weight on determination and ifm-2009 and try to extrapolate to older patients. #mmsm #ash22
Asst Professor at University of Chicago, specializing in (vanquishing) plasma cell disorders. I tweet about: Myeloma & MRD. https://t.co/mPeWg1QRrW